218 related articles for article (PubMed ID: 31403697)
1. Transition from mesenchymal to bleb-based motility is predominantly exhibited by CD133-positive subpopulation of fibrosarcoma cells.
Chikina AS; Rubtsova SN; Lomakina ME; Potashnikova DM; Vorobjev IA; Alexandrova AY
Biol Cell; 2019 Oct; 111(10):245-261. PubMed ID: 31403697
[TBL] [Abstract][Full Text] [Related]
2. CD133+ subpopulation of the HT1080 human fibrosarcoma cell line exhibits cancer stem-like characteristics.
Feng BH; Liu AG; Gu WG; Deng L; Cheng XG; Tong TJ; Zhang HZ
Oncol Rep; 2013 Aug; 30(2):815-23. PubMed ID: 23708735
[TBL] [Abstract][Full Text] [Related]
3. Actin cytoskeleton in mesenchymal-to-amoeboid transition of cancer cells.
Alexandrova AY; Chikina AS; Svitkina TM
Int Rev Cell Mol Biol; 2020; 356():197-256. PubMed ID: 33066874
[TBL] [Abstract][Full Text] [Related]
4. Actin cytoskeleton regulator Arp2/3 complex is required for DLL1 activating Notch1 signaling to maintain the stem cell phenotype of glioma initiating cells.
Zhang C; Hai L; Zhu M; Yu S; Li T; Lin Y; Liu B; Zhou X; Chen L; Zhao P; Zhou H; Huang Y; Zhang K; Ren B; Yang X
Oncotarget; 2017 May; 8(20):33353-33364. PubMed ID: 28380416
[TBL] [Abstract][Full Text] [Related]
5. Time-resolved ultrastructure of the cortical actin cytoskeleton in dynamic membrane blebs.
Chikina AS; Svitkina TM; Alexandrova AY
J Cell Biol; 2019 Feb; 218(2):445-454. PubMed ID: 30541746
[TBL] [Abstract][Full Text] [Related]
6. Met-induced membrane blebbing leads to amoeboid cell motility and invasion.
Laser-Azogui A; Diamant-Levi T; Israeli S; Roytman Y; Tsarfaty I
Oncogene; 2014 Apr; 33(14):1788-98. PubMed ID: 23665680
[TBL] [Abstract][Full Text] [Related]
7. Hypoxia Induces a HIF-1-Dependent Transition from Collective-to-Amoeboid Dissemination in Epithelial Cancer Cells.
Lehmann S; Te Boekhorst V; Odenthal J; Bianchi R; van Helvert S; Ikenberg K; Ilina O; Stoma S; Xandry J; Jiang L; Grenman R; Rudin M; Friedl P
Curr Biol; 2017 Feb; 27(3):392-400. PubMed ID: 28089517
[TBL] [Abstract][Full Text] [Related]
8. CCL21/CCR7 Axis Contributed to CD133+ Pancreatic Cancer Stem-Like Cell Metastasis via EMT and Erk/NF-κB Pathway.
Zhang L; Wang D; Li Y; Liu Y; Xie X; Wu Y; Zhou Y; Ren J; Zhang J; Zhu H; Su Z
PLoS One; 2016; 11(8):e0158529. PubMed ID: 27505247
[TBL] [Abstract][Full Text] [Related]
9. Effect of CD133 overexpression on the epithelial-to-mesenchymal transition in oral cancer cell lines.
Moon Y; Kim D; Sohn H; Lim W
Clin Exp Metastasis; 2016 Jun; 33(5):487-96. PubMed ID: 27137188
[TBL] [Abstract][Full Text] [Related]
10. Plasma Membrane Blebbing Is Controlled by Subcellular Distribution of Vimentin Intermediate Filaments.
Chikina AS; Zholudeva AO; Lomakina ME; Kireev II; Dayal AA; Minin AA; Maurin M; Svitkina TM; Alexandrova AY
Cells; 2024 Jan; 13(1):. PubMed ID: 38201309
[TBL] [Abstract][Full Text] [Related]
11. The amoeboid state as part of the epithelial-to-mesenchymal transition programme.
Graziani V; Rodriguez-Hernandez I; Maiques O; Sanz-Moreno V
Trends Cell Biol; 2022 Mar; 32(3):228-242. PubMed ID: 34836782
[TBL] [Abstract][Full Text] [Related]
12. RASSF1C oncogene elicits amoeboid invasion, cancer stemness, and extracellular vesicle release via a SRC/Rho axis.
Tognoli ML; Vlahov N; Steenbeek S; Grawenda AM; Eyres M; Cano-Rodriguez D; Scrace S; Kartsonaki C; von Kriegsheim A; Willms E; Wood MJ; Rots MG; van Rheenen J; O'Neill E; Pankova D
EMBO J; 2021 Oct; 40(20):e107680. PubMed ID: 34532864
[TBL] [Abstract][Full Text] [Related]
13. Partial loss of actin nucleator actin-related protein 2/3 activity triggers blebbing in primary T lymphocytes.
Obeidy P; Ju LA; Oehlers SH; Zulkhernain NS; Lee Q; Galeano Niño JL; Kwan RY; Tikoo S; Cavanagh LL; Mrass P; Cook AJ; Jackson SP; Biro M; Roediger B; Sixt M; Weninger W
Immunol Cell Biol; 2020 Feb; 98(2):93-113. PubMed ID: 31698518
[TBL] [Abstract][Full Text] [Related]
14. HERV-K activation is strictly required to sustain CD133+ melanoma cells with stemness features.
Argaw-Denboba A; Balestrieri E; Serafino A; Cipriani C; Bucci I; Sorrentino R; Sciamanna I; Gambacurta A; Sinibaldi-Vallebona P; Matteucci C
J Exp Clin Cancer Res; 2017 Jan; 36(1):20. PubMed ID: 28125999
[TBL] [Abstract][Full Text] [Related]
15. Acquisition of tumorigenic potential and therapeutic resistance in CD133+ subpopulation of prostate cancer cells exhibiting stem-cell like characteristics.
Kanwal R; Shukla S; Walker E; Gupta S
Cancer Lett; 2018 Aug; 430():25-33. PubMed ID: 29775627
[TBL] [Abstract][Full Text] [Related]
16. Impairment of Assembly of the Vimentin Intermediate Filaments Leads to Suppression of Formation and Maturation of Focal Contacts and Alteration of the Type of Cellular Protrusions.
Zholudeva AO; Potapov NS; Kozlova EA; Lomakina ME; Alexandrova AY
Biochemistry (Mosc); 2024 Jan; 89(1):184-195. PubMed ID: 38467554
[TBL] [Abstract][Full Text] [Related]
17. An In Vitro System to Study the Mesenchymal-to-Amoeboid Transition.
Chikina AS; Alexandrova AY
Methods Mol Biol; 2018; 1749():21-27. PubMed ID: 29525987
[TBL] [Abstract][Full Text] [Related]
18. IL-6 promotes growth and epithelial-mesenchymal transition of CD133+ cells of non-small cell lung cancer.
Lee SO; Yang X; Duan S; Tsai Y; Strojny LR; Keng P; Chen Y
Oncotarget; 2016 Feb; 7(6):6626-38. PubMed ID: 26675547
[TBL] [Abstract][Full Text] [Related]
19. Down-regulation of phosphoglucose isomerase/autocrine motility factor results in mesenchymal-to-epithelial transition of human lung fibrosarcoma cells.
Funasaka T; Hu H; Yanagawa T; Hogan V; Raz A
Cancer Res; 2007 May; 67(9):4236-43. PubMed ID: 17483335
[TBL] [Abstract][Full Text] [Related]
20. Novel antibody reagents for characterization of drug- and tumor microenvironment-induced changes in epithelial-mesenchymal transition and cancer stem cells.
Navas T; Pfister TD; Colantonio S; Aziz A; Dieckman L; Saul RG; Kaczmarczyk J; Borgel S; Alcoser SY; Hollingshead MG; Lee YH; Bottaro DP; Hiltke T; Whiteley G; Takebe N; Kinders RJ; Parchment RE; Tomaszewski JE; Doroshow JH
PLoS One; 2018; 13(6):e0199361. PubMed ID: 29928062
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
